A Study to Assess the Drug-drug Interaction of BMS-963272 and Rosuvastatin

Clinical trial NCT04124003 · COMPLETED

Trial details

NCT number: NCT04124003
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants

Start date: 2019-10-08
Primary completion: 2020-01-03
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.